
Damian Garde
Reporter at Bloomberg News
@business reporter covering pharma / [email protected] / Signal: damiangarde.67
Articles
-
1 week ago |
gazettextra.com | Rachel Zhang |Gerry Smith |Damian Garde
WASHINGTON - Robert F. Kennedy Jr.'s plan for America's vaccines is coming into focus, with his revamped immunization advisory panel set to discuss the use of measles shots in kids next week and vote on an ingredient that's been wrongly linked to autism. The draft agenda for next week's Advisory Committee on Immunization Practices meeting revisits old topics concerning vaccine safety, raising questions that many public health experts consider long settled.
-
1 week ago |
thebrunswicknews.com | Rachel Zhang |Gerry Smith |Damian Garde
WASHINGTON - Robert F. Kennedy Jr.'s plan for America's vaccines is coming into focus, with his revamped immunization advisory panel set to discuss the use of measles shots in kids next week and vote on an ingredient that's been wrongly linked to autism. The draft agenda for next week's Advisory Committee on Immunization Practices meeting revisits old topics concerning vaccine safety, raising questions that many public health experts consider long settled.
-
1 week ago |
mahoningmatters.com | Rachel Zhang |Gerry Smith |Damian Garde
WASHINGTON - Robert F. Kennedy Jr.'s plan for America's vaccines is coming into focus, with his revamped immunization advisory panel set to discuss the use of measles shots in kids next week and vote on an ingredient that's been wrongly linked to autism. The draft agenda for next week's Advisory Committee on Immunization Practices meeting revisits old topics concerning vaccine safety, raising questions that many public health experts consider long settled.
-
1 week ago |
bloomberg.com | Rachel Zhang |Gerry Smith |Damian Garde
A nurse prepares vaccines at a vaccination site in Los Angeles. (Bloomberg) -- Robert F. Kennedy Jr.’s plan for America’s vaccines is coming into focus, with his revamped immunization advisory panel set to discuss the use of measles shots in kids next week and vote on an ingredient that’s been wrongly linked to autism.
-
2 weeks ago |
bloomberg.com | Gerry Smith |Rachel Zhang |Damian Garde
Syringes with doses of the Pfizer-BioNTech Covid-19 pediatric vaccine at a Salvation Army vaccination clinic in Philadelphia, Pennsylvania, U.S., on Friday, Nov. 12, 2021. The Pfizer-BioNTech Covid-19 vaccines for children ages 5 to 11-year-old are a third of the dose that adults receive. (Bloomberg) -- Robert F.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 16K
- Tweets
- 11K
- DMs Open
- Yes

RT @gerryfsmith: New: At least seven people have died in the US from symptoms linked to a new Alzheimer's drug over the past two years. Reg…

White House Pulls CDC Pick Who Was Facing Likely Senate Defeat https://t.co/BbGqI09i0h

Trump’s CDC Pick Is Still Pushing Vaccine-Autism ‘Lie,’ Senator Says https://t.co/9vCIMY9CsK